Home Other Building Blocks 81403-68-1
81403-68-1,MFCD00879135
Catalog No.:AA0052MG

81403-68-1 | Alfuzosin hydrochloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
98%
in stock  
$32.00   $23.00
- +
25mg
98%
in stock  
$47.00   $33.00
- +
100mg
>98.0%(HPLC)
in stock  
$61.00   $43.00
- +
1g
>98.0%(HPLC)
in stock  
$271.00   $190.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA0052MG
Chemical Name:
Alfuzosin hydrochloride
CAS Number:
81403-68-1
Molecular Formula:
C19H28ClN5O4
Molecular Weight:
425.9097
MDL Number:
MFCD00879135
SMILES:
COc1cc2nc(nc(c2cc1OC)N)N(CCCNC(=O)C1CCCO1)C.Cl
Properties
Properties
 
BP:
687.7°C at 760 mmHg  
Form:
Solid  
MP:
226-229°C  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
511  
Covalently-Bonded Unit Count:
2  
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
8  
Undefined Atom Stereocenter Count:
1  

Literature

Title: Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20131201

Title: Effects of alfuzosin with methylprednisolone for spontaneous expulsion and pain control of lower ureteral stone.

Journal: Urological research 20121001

Title: Alpha-blockers impact stent-related symptoms: a randomized, double-blind, placebo-controlled trial.

Journal: Journal of endourology 20120901

Title: Statistical approach for assessing the influence of calcium silicate and HPMC on the formulation of novel alfuzosin hydrochloride mucoadhesive-floating beads as gastroretentive drug delivery systems.

Journal: AAPS PharmSciTech 20120901

Title: Comparison of the effects of four α1-adrenoceptor antagonists on ejaculatory function in rats.

Journal: Urology 20120801

Title: Impact of alfuzosin on sexual function in Taiwanese men with benign prostatic hyperplasia.

Journal: The Kaohsiung journal of medical sciences 20120801

Title: Alfuzosin for the treatment of storage symptoms suggestive of overactive bladder.

Journal: Expert opinion on pharmacotherapy 20120601

Title: Efficacy of alfuzosin and sildenafil combination in male patients with lower urinary tract symptoms.

Journal: Andrologia 20120501

Title: Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes.

Journal: Journal of pharmacy practice 20120401

Title: The effect of alpha antagonists on pupil dynamics: implications for the diagnosis of intraoperative floppy iris syndrome.

Journal: American journal of ophthalmology 20120401

Title: Evaluation of a column classification method using the separation of alfuzosin from its related substances.

Journal: Journal of chromatography. A 20120316

Title: In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride.

Journal: Pharmaceutical development and technology 20120101

Title: Chronic pelvic pain syndrome and semen quality of Korean men in their fourth decade.

Journal: Journal of andrology 20120101

Title: Lipases as catalysts in synthesis of fine chemicals.

Journal: Methods in molecular biology (Clifton, N.J.) 20120101

Title: Randomized crossover comparison of tamsulosin and alfuzosin in patients with urinary disturbances caused by benign prostatic hyperplasia.

Journal: International urology and nephrology 20111201

Title: Effects of pulsed electromagnetic fields on benign prostate hyperplasia.

Journal: International urology and nephrology 20111201

Title: Imatinib mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue.

Journal: Urology 20111001

Title: Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20110901

Title: Treatment with a uroselective α1-blocker improves voiding and sexual function: a study in Thai men with lower urinary tract symptoms.

Journal: The journal of sexual medicine 20110901

Title: Comparison of alpha-blocker, extracorporeal magnetic stimulation alone and in combination in the management of female bladder outlet obstruction.

Journal: International urogynecology journal 20110701

Title: Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions.

Journal: Analytical and bioanalytical chemistry 20110701

Title: Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10mm: a prospective randomized controlled trial.

Journal: International journal of urology : official journal of the Japanese Urological Association 20110701

Title: Postural hypotension.

Journal: BMJ (Clinical research ed.) 20110616

Title: Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia.

Journal: Urology 20110601

Title: The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility.

Journal: Urology 20110501

Title: Risk factors for intraoperative floppy iris syndrome: a meta-analysis.

Journal: Ophthalmology 20110401

Title: Influence of chemical permeation enhancers on transdermal permeation of alfuzosin: an investigation using response surface modeling.

Journal: Drug development and industrial pharmacy 20110401

Title: Efficacy and safety of low-dose propiverine in patients with lower urinary tract symptoms/benign prostatic hyperplasia with storage symptoms: a prospective, randomized, single-blinded and multicenter clinical trial.

Journal: Korean journal of urology 20110401

Title: Most bothersome symptom and symptom specific goal achievement in patients with benign prostatic obstruction: a prospective open label study.

Journal: The Journal of urology 20110301

Title: [Recurrent hepatocellular lesion due to alfuzosin].

Journal: Gastroenterologia y hepatologia 20110201

Title: [Efficacy of prostatic adenoma treatment with alfusozine depending on sexuality].

Journal: Urologiia (Moscow, Russia : 1999) 20110101

Title: Efficacy of three different alpha 1-adrenergic blockers and hyoscine N-butylbromide for distal ureteral stones.

Journal: International braz j urol : official journal of the Brazilian Society of Urology 20110101

Title: Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension.

Journal: Prostate cancer and prostatic diseases 20101201

Title: Alfuzosin induced thrombocytopenia after treatment for benign prostatic hyperplasia.

Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20101201

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: [Our experience with the use of alpha-lithic therapy in the treatment of voiding dysfunction].

Journal: Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica 20101001

Title: Sexuality and management of benign prostatic hyperplasia with alfuzosin: SAMBA Thailand.

Journal: The journal of sexual medicine 20100901

Title: Generalized skin drug eruption to natalizumab in a patient with multiple sclerosis.

Journal: Dermatology online journal 20100615

Title: Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.

Journal: Urology 20100601

Title: [Alpha-1-blockers (alfuzosin) for obstructive salivary gland diseases].

Journal: Revue de stomatologie et de chirurgie maxillo-faciale 20100601

Title: Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.

Journal: The Journal of urology 20100501

Title: Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human detrusor and prostatic tissues in vitro.

Journal: European urology 20100401

Title: An open, non-comparative, multicentre study on the impact of alfuzosin on sexual function using the Male Sexual Health Questionnaire in patients with benign prostate hyperplasia.

Journal: International journal of clinical practice 20100201

Title: The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms.

Journal: Journal of endourology 20091101

Title: Alpha blockers prior to removal of a catheter for acute urinary retention in adult men.

Journal: The Cochrane database of systematic reviews 20091007

Title: [Use of alfuzosin for expulsion of stones in the distal third of ureter].

Journal: Actas urologicas espanolas 20091001

Title: Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?

Journal: BJU international 20090801

Title: Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.

Journal: Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20090801

Title: Quantitation of alfuzosin hydrochloride in pharmaceutical formulations by RP-HPLC.

Journal: Pakistan journal of pharmaceutical sciences 20090701

Title: Application of a novel symmetrical shape factor to gastroretentive matrices as a measure of swelling synchronization and its impact on drug release kinetics under standard and modified dissolution conditions.

Journal: The Journal of pharmacy and pharmacology 20090701

Title: Safety and efficacy of a prolonged-release formulation of alfuzosin 10 mg once daily in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090701

Title: Breast cancer resistance protein interacts with various compounds in vitro, but plays a minor role in substrate efflux at the blood-brain barrier.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20090601

Title: Prospective randomized trial comparing efficacy of alfuzosin and tamsulosin in management of lower ureteral stones.

Journal: Urology 20090401

Title: Prostatitis: no benefit of alpha-blockers for chronic prostatitis.

Journal: Nature reviews. Urology 20090401

Title: Functional screening of adrenergic receptors by measuring intracellular calcium using the FlexStation scanning fluorimeter.

Journal: Biotechnology journal 20090301

Title: Effect of alfuzosin on female primary bladder neck obstruction.

Journal: International urogynecology journal and pelvic floor dysfunction 20090201

Title: Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report.

Journal: The journal of sexual medicine 20090201

Title: Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study.

Journal: The Journal of urology 20090101

Title: Watchful waiting in benign prostatic hyperplasia.

Journal: Current opinion in urology 20090101

Title: Sexuality and the management of BPH with alfuzosin (SAMBA) trial.

Journal: International journal of impotence research 20090101

Title: Effects of alfuzosin and tamsulosin on sperm parameters in healthy men: results of a short-term, randomized, double-blind, placebo-controlled, crossover study.

Journal: Journal of andrology 20090101

Title: Can open-label studies demonstrate efficacy in improving sexual function?

Journal: International journal of impotence research 20090101

Title: Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.

Journal: Urologia internationalis 20090101

Title: Alfuzosin hydrochloride transdermal films: evaluation of physicochemical, in vitro human cadaver skin permeation and thermodynamic parameters.

Journal: International braz j urol : official journal of the Brazilian Society of Urology 20090101

Title: Efficacy of alpha-Adrenergic Receptor Blockers in the Treatment of Male Lower Urinary Tract Symptoms.

Journal: Reviews in urology 20090101

Title: [Administration of two uroselective alpha-adrenoblockers in pharmacological treatment of acute urinary retention in patients with prostatic adenoma].

Journal: Urologiia (Moscow, Russia : 1999) 20090101

Title: Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome.

Journal: The New England journal of medicine 20081218

Title: Highly sensitive and rapid LC-ESI-MS/MS method for the simultaneous quantification of uroselective alpha1-blocker, alfuzosin and an antimuscarinic agent, solifenacin in human plasma.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081215

Title: Alfuzosin attenuates erectile dysfunction in rats with partial bladder outlet obstruction.

Journal: BJU international 20081201

Title: Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily.

Journal: Clinical interventions in aging 20080901

Title: Selective and automated sample pretreatment by molecularly imprinted polymer for the analysis of the basic drug alfuzosin from plasma.

Journal: Journal of chromatography. A 20080704

Title: Intraoperative floppy-iris syndrome associated with systemic alpha blockers.

Journal: Journal of cataract and refractive surgery 20080701

Title: Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study.

Journal: The Journal of urology 20080601

Title: [Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?].

Journal: Harefuah 20080601

Title: Combination of alfuzosin and tadalafil exerts in vitro an additive relaxant effect on human corpus cavernosum.

Journal: The journal of sexual medicine 20080401

Title: Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.

Journal: BJU international 20080401

Title: Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles: possible model for intraoperative floppy-iris syndrome.

Journal: Journal of cataract and refractive surgery 20080301

Title: The concept of neurogenic inflammation.

Journal: BJU international 20080301

Title: Role of alpha1-blockers in chronic prostatitis syndromes.

Journal: BJU international 20080301

Title: Zero-order delivery of a highly soluble, low dose drug alfuzosin hydrochloride via gastro-retentive system.

Journal: International journal of pharmaceutics 20080204

Title: In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.

Journal: European journal of pharmacology 20080202

Title: Alfuzosin delays cardiac repolarization by a novel mechanism.

Journal: The Journal of pharmacology and experimental therapeutics 20080201

Title: Comparing the therapeutic outcome of different alpha-blocker treatments for BPH in the same individuals.

Journal: International urology and nephrology 20080101

Title: The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation.

Journal: Annals of ophthalmology (Skokie, Ill.) 20080101

Title: Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay.

Journal: European journal of pharmacology 20071222

Title: Stability-indicating spectrophotometric and spectrofluorimetric methods for determination of alfuzosin hydrochloride in the presence of its degradation products.

Journal: Die Pharmazie 20071101

Title: The influence of alpha1-adrenoreceptors on neuropeptide release from primary sensory neurons of the lower urinary tract.

Journal: European urology 20070901

Title: Alfuzosin-induced acute liver injury.

Journal: The Korean journal of hepatology 20070901

Title: Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study.

Journal: The Journal of urology 20070801

Title: Potentiometric sensors enabling fast screening of the benign prostatic hyperplasia drug alfuzosin in pharmaceuticals, urine and serum.

Journal: Combinatorial chemistry & high throughput screening 20070801

Title: Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin.

Journal: Journal of cataract and refractive surgery 20070701

Title: Selective sample treatment using molecularly imprinted polymers.

Journal: Journal of chromatography. A 20070608

Title: Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.

Journal: European urology 20070601

Title: Lower urinary tract symptoms (LUTS) and sexual dysfunction (SD): new targets for new combination therapies?

Journal: European urology 20070601

Title: Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha1-adrenoceptor antagonist.

Journal: American journal of ophthalmology 20070601

Title: Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.

Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20070601

Title: Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome.

Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20070601

Title: The effects of two systemic alpha1-adrenergic blockers on pupil diameter: a prospective randomized single-blind study.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20070501

Title: Re: Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers: W. J. Hellstrom and S. C. Sikka. J Urol 2006; 176: 1529-1533.

Journal: The Journal of urology 20070401

Title: Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial.

Journal: Prostate cancer and prostatic diseases 20070101

Title: Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia.

Journal: International journal of impotence research 20070101

Title: In vitro controlled release of alfuzosin hydrochloride using HPMC-based matrix tablets and its comparison with marketed product.

Journal: Pharmaceutical development and technology 20070101

Title: [The experience in postoperative administration of alpha-adrenoblockers].

Journal: Urologiia (Moscow, Russia : 1999) 20070101

Title: Intraoperative floppy iris syndrome in a patient taking alfuzosin for benign prostatic hypertrophy.

Journal: Eye (London, England) 20061201

Title: Alfuzosin (10 mg) does not affect blood pressure in young healthy men.

Journal: European urology 20061201

Title: Molecularly imprinted polymers for the clean-up of a basic drug from environmental and biological samples.

Journal: Journal of chromatography. A 20061201

Title: Validated HPLC and HPTLC stability-indicating methods for determination of alfuzosin hydrochloride in bulk powder and pharmaceutical formulations.

Journal: Journal of separation science 20061201

Title: Urethral syndrome: response to alpha-adrenergic blocking agents.

Journal: International urogynecology journal and pelvic floor dysfunction 20061101

Title: Comparison between tamsulosin and alfuzosin on the expulsion phase of ejaculation in rats.

Journal: BJU international 20061001

Title: Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers.

Journal: The Journal of urology 20061001

Title: Stuttering priapism after ingestion of alfuzosin.

Journal: Urology 20061001

Title: Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.

Journal: The Journal of urology 20060901

Title: Toxic epidermal necrolysis caused by alfuzosin, an alpha1-adrenoceptor antagonist.

Journal: Archives of dermatology 20060701

Title: The management of chronic prostatitis in men with HIV.

Journal: Current urology reports 20060701

Title: The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.

Journal: BJU international 20060601

Title: Hemodynamic interaction study between the alpha1-blocker alfuzosin and the phosphodiesterase-5 inhibitor tadalafil in middle-aged healthy male subjects.

Journal: Urology 20060601

Title: The natural history of benign prostatic hyperplasia.

Journal: BJU international 20060401

Title: Definition of at-risk patients: dynamic variables.

Journal: BJU international 20060401

Title: Tablet induced dysphagia in oesophageal cancer.

Journal: Gut 20060401

Title: The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.

Journal: BJU international 20060401

Title: Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.

Journal: BJU international 20060401

Title: Alfuzosin: an alpha1-receptor blocker for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.

Journal: Expert opinion on pharmacotherapy 20060401

Title: Treatment and pharmacologic management of BPH in the context of common comorbidities.

Journal: The American journal of managed care 20060401

Title: Are all alpha-blockers created the same?

Journal: European urology 20060301

Title: Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL).

Journal: European urology 20060301

Title: Dynamic variables: novel and perhaps better predictors of progression in benign prostatic hyperplasia.

Journal: BJU international 20060301

Title: Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice.

Journal: BJU international 20060301

Title: What's the point?

Journal: BJU international 20060301

Title: Efficacy and safety of alfuzosin 10 mg once daily in the treatment of symptomatic benign prostatic hyperplasia.

Journal: International journal of clinical practice 20060301

Title: Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once daily.

Journal: The Journal of urology 20060201

Title: In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20060201

Title: Three months' treatment with the alpha1-blocker alfuzosin does not affect total or transition zone volume of the prostate.

Journal: Prostate cancer and prostatic diseases 20060101

Title: Effects of selective alpha-1-adrenergic receptor blockers on bladder weight.

Journal: Urologia internationalis 20060101

Title: Alfuzosin for symptomatic benign prostatic hyperplasia: long-term experience.

Journal: The Journal of urology 20060101

Title: Is there a role for alpha1-blockers in treating double-J stent-related symptoms?

Journal: Urology 20060101

Title: Obstructive primary bladder neck disease: evaluation of the efficacy and safety of alpha1-blockers.

Journal: Urologia internationalis 20060101

Title: Effects of alpha(1)-adrenoceptor antagonists on male sexual function.

Journal: Drugs 20060101

Title: 'Ejaculatory disorders and alpha1-adrenoceptor antagonists therapy: clinical and experimental researches'.

Journal: Journal of translational medicine 20060101

Title: [Diagnosis and treatment of urinary bladder dysfunctions in patients with nephrotuberculosis].

Journal: Urologiia (Moscow, Russia : 1999) 20060101

Title: A prospective pilot study to validate the management protocol for patients presenting with acute urinary retention: a community-based, nonhospitalised protocol.

Journal: TheScientificWorldJournal 20060101

Title: Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg?

Journal: Ophthalmology 20051201

Title: Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.

Journal: The Journal of urology 20051101

Title: Alfuzosin for treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: a systematic review of efficacy and adverse effects.

Journal: Urology 20051001

Title: Effects of different alpha-1 adrenoceptor blockers on proximal urethral function using in vivo isovolumetric pressure changes.

Journal: Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20051001

Title: The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysis.

Journal: BJU international 20050901

Title: Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily.

Journal: Urology 20050801

Title: Early symptom improvement of benign prostatic hyperplasia (BPH) treated with once daily alfuzosin.

Journal: The Canadian journal of urology 20050801

Title: Re: Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention.

Journal: The Journal of urology 20050701

Title: Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia.

Journal: BJU international 20050501

Title: Clinical assessment of drug-induced QT prolongation in association with heart rate changes.

Journal: Clinical pharmacology and therapeutics 20050401

Title: Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.

Journal: BJU international 20050301

Title: Re: alfuzosin once daily facilitates return to voiding in patients in acute urinary retention.

Journal: The Journal of urology 20050301

Title: The vasodilatory effect of alfuzosin and tamsulosin in passive orthostasis: a randomised, double-blind, placebo-controlled study.

Journal: European urology 20050301

Title: Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance to ejaculation delays.

Journal: The Journal of pharmacology and experimental therapeutics 20050201

Title: Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.

Journal: Urology 20050101

Title: [The role of alpha1-adrenoblocker alfuzosine in diagnostic-therapeutic algorithm of hyperactive urinary bladder management in women and selection of patients for treatment with M-cholinergic antagonists].

Journal: Urologiia (Moscow, Russia : 1999) 20050101

Title: A comparative study on the safety and efficacy of tamsulosin and alfuzosin in the management of symptomatic benign prostatic hyperplasia: a randomized controlled clinical trial.

Journal: The Journal of international medical research 20050101

Title: Long term follow up of men with Alfuzosin who voided successfully following acute urinary retention*.

Journal: International urology and nephrology 20050101

Title: Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.

Journal: Clinical therapeutics 20041101

Title: Alfuzosin-induced acute hepatitis in a patient with chronic liver disease.

Journal: The Annals of pharmacotherapy 20040901

Title: Prostate size influences the outcome after presenting with acute urinary retention.

Journal: BJU international 20040901

Title: New drugs 04. Part III.

Journal: Nursing 20040901

Title: Ejaculatory dysfunction and alpha-adrenoceptor antagonists.

Journal: BJU international 20040801

Title: [A suggested treatment algorithm in nocturnal enuresis with emphasis on partial responders].

Journal: Der Urologe. Ausg. A 20040701

Title: Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention.

Journal: The Journal of urology 20040601

Title: On call. My doctor gave me a prescription for Uroxatral to treat my enlarged prostate. I tried to look up this medicine in your Harvard Medical School Guide to Men's Health, but I couldn't find it. What can you tell me about Uroxatral?

Journal: Harvard men's health watch 20040601

Title: [The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line].

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery] 20040522

Title: Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement.

Journal: BJU international 20040401

Title: Priapism as a possible acute side effect of radical radiotherapy for prostate cancer.

Journal: The Canadian journal of urology 20040401

Title: A comparison of the effects of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rats.

Journal: BJU international 20040301

Title: Extended-release alfuzosin hydrochloride: a new alpha-adrenergic receptor antagonist for symptomatic benign prostatic hyperplasia.

Journal: The American journal of geriatric pharmacotherapy 20040301

Title: A current review of medical therapy for benign prostatic hyperplasia.

Journal: The Journal of the American Osteopathic Association 20040201

Title: Alfuzosin (uroxatral)--another alpha1-blocker for benign prostatic hyperplasia.

Journal: The Medical letter on drugs and therapeutics 20040105

Title: Alfuzosin improves penile erection triggered by apomorphine in spontaneous hypertensive rats.

Journal: European urology 20040101

Title: [Can selective alpha-blockers help the spontaneous passage of the stones located in the uretero-bladder junction?].

Journal: Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20040101

Title: A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.

Journal: Scandinavian journal of urology and nephrology 20040101

Title: Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies.

Journal: BJU international 20031201

Title: Alfuzosin for the management of benign prostate hyperplasia.

Journal: Expert opinion on pharmacotherapy 20031101

Title: First dose efficacy of alfuzosin once daily in men with symptomatic benign prostatic hyperplasia.

Journal: Urology 20031101

Title: [Pharmacologic treatment of benign prostatic hyperplasia].

Journal: Orvosi hetilap 20030914

Title: Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.

Journal: Urology 20030901

Title: Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies.

Journal: BJU international 20030801

Title: Alfuzosin hydrochloride for the treatment of benign prostatic hyperplasia.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030715

Title: Prostatic tissual distribution of alfuzosin in patients with benign prostatic hyperplasia following repeated oral administration.

Journal: European urology 20030701

Title: Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003.

Journal: Circulation 20030617

Title: Comparison of the relaxant effects of alfuzosin, phentolamine and sildenafil on rabbit isolated corpus cavernosum.

Journal: BJU international 20030601

Title: Selective, sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of alfuzosin in human plasma.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030525

Title: Current treatment options for benign prostatic hyperplasia and their impact on sexual function.

Journal: Urology 20030401

Title: Benign prostatic hyperplasia.

Journal: Hospital medicine (London, England : 1998) 20030201

Title: Clinical and pressure-flow changes after long-term treatment with alfuzosin SR.

Journal: Urologia internationalis 20030101

Title: Pharmacokinetics and safety of a single oral dose of once-daily alfuzosin, 10 mg, in male subjects with mild to severe renal impairment.

Journal: Journal of clinical pharmacology 20021201

Title: Alfuzosin in the treatment of high leak-point pressure in children with neurogenic bladder.

Journal: BJU international 20021101

Title: Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention.

Journal: European urology 20021001

Title: Alfuzosin, an alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia: once daily versus 3 times daily dosing in healthy subjects.

Journal: International journal of clinical pharmacology and therapeutics 20020701

Title: [Chiral separation and preparation of three new antagonists of alpha 1-adrenoceptors by chiral mobile phase HPLC].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20020601

Title: Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms.

Journal: The Journal of urology 20020401

Title: Alfuzosin: a clinically uroselective alpha1-blocker.

Journal: World journal of urology 20020401

Title: The use of alpha-adrenoceptor antagonists in lower urinary tract disease.

Journal: Expert opinion on pharmacotherapy 20020201

Title: [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].

Journal: Urologiia (Moscow, Russia : 1999) 20020101

Title: Alfuzosin: a review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia.

Journal: Drugs 20020101

Title: Long-term safety and efficacy of a once-daily formulation of alfuzosin 10 mg in patients with symptomatic benign prostatic hyperplasia: open-label extension study.

Journal: European urology 20020101

Title: Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial.

Journal: Urology 20011201

Title: Alfuzosin: overview of pharmacokinetics, safety, and efficacy of a clinically uroselective alpha-blocker.

Journal: Urology 20011201

Title: Worldwide experience with alfuzosin and tamsulosin.

Journal: Urology 20011001

Title: Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations.

Journal: Journal of clinical epidemiology 20010501

Title: Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin.

Journal: Urology 20010301

Title: Does acute urinary retention respond to alpha-blockers alone?

Journal: European urology 20010301

Title: The efficacy and safety of a new once-a-day formulation of an alpha-blocker.

Journal: European urology 20010301

Title: [Long-term therapy of benign prostatic hyperplasia. Our experience].

Journal: Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20010301

Title: alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it.

Journal: The Journal of urology 20010101

Title: A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20010101

Title: [Effectiveness of various alfuzosin schedules in patients with benign prostatic hyperplasia (BPH)].

Journal: Urologiia (Moscow, Russia : 1999) 20010101

Title: [Dalphaz-retard treatment of urination disorders in men and women].

Journal: Urologiia (Moscow, Russia : 1999) 20010101

Title: Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia.

Journal: International urology and nephrology 20010101

Title: Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia.

Journal: International urology and nephrology 20010101

Title: The efficacy of alfuzosin treatment in patients with prostatism.

Journal: International urology and nephrology 20010101

Title: A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.

Journal: European urology 19990101

Title: [Combined use of 5 alpha-reductase inhibitors and alpha-l adrenergic receptor blockers in patients with benign prostatic hyperplasia].

Journal: Urologiia i nefrologiia 19980101

Title: Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group.

Journal: British journal of urology 19971001

Title: Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes.

Journal: The Prostate 19970915

Title: Prostatic alpha 1-adrenoceptors and uroselectivity.

Journal: The Prostate 19970215

Title: Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy.

Journal: European journal of pharmacology 19950116

Title: [Assessment of the effects of alfuzosin on miction with dynamic echography].

Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 19940901

Title: Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.

Journal: Urology 19940701

Title: The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.

Journal: Molecular pharmacology 19940401

Title: Alfuzosin in the treatment of benign prostatic hyperplasia: effects on symptom scores, urinary flow rates and residual volume. A multicentre, double-blind, placebo-controlled trial. ALFECH Study Group.

Journal: Scandinavian journal of urology and nephrology. Supplementum 19940101

Title: [Use of terazosin and alfuzosin in the treatment of benign prostatic hypertrophy (BPH): our experience].

Journal: Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma 19940101

Title: Identification of alpha 1-adrenoceptor subtypes present in the human prostate.

Journal: Life sciences 19940101

Title: Alpha-blocking treatment with alfuzosin in symptomatic benign prostatic hyperplasia: comparative study with prazosin. The PRAZALF Group.

Journal: British journal of urology 19931201

Title: The effect of cimetidine on the pharmacokinetics of single oral doses of alfuzosin.

Journal: International journal of clinical pharmacology, therapy, and toxicology 19931101

Title: Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract.

Journal: British journal of pharmacology 19930801

Title: Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Journal: Drugs 19930301

Title: [Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas].

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 19920301

Title: Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities.

Journal: European urology 19920101

Title: Peripubertal changes in the nature of the GnRH response to alpha-adrenoceptor stimulation in vitro and their modulation by testosterone.

Journal: Neuroendocrinology 19900701

Title: A comparison of the effects of doxazosin and alfuzosin with those of urapidil on preganglionic sympathetic nerve activity in anaesthetised cats.

Journal: European journal of pharmacology 19861007

Title: Wilde MI, et al. Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs. 1993 Mar;45(3):410-29.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:81403-68-1 Molecular Formula|81403-68-1 MDL|81403-68-1 SMILES|81403-68-1 Alfuzosin hydrochloride